Although 80% of medtech companies have undertaken major cost programs over the past five years, only 10% reported achieving all of their goals, according to a recent Bain survey. A key reason for the poor track record, medtech executives say, is the lack of spending visibility and accountability. Only 24% of executives feel that their organization performs “very well” on spending accountability, and fewer than 12% feel that way about how their organization allocates spending. To address that shortcoming, leading medtech companies are testing a more radical approach to cost management—zero-based budgeting (ZBB)—which improves visibility and holds individuals accountable for achieving savings.
Patrick O’Hagan and Jason Evers are partners with Bain & Company’s Healthcare practice. Patrick is based in the firm’s Boston office, and Jason is based in Chicago.
Zero-based budgeting vastly improves spending visibility and accountability.